ESC 365 - Apixaban in patients undergoing atrial fibrillation ablation

EHRA Premium Access

Apixaban in patients undergoing atrial fibrillation ablation

Session: Late-Breaking Trials

Topic: Catheter Ablation of Arrhythmias

Speaker: Professor P. Kirchhof (Hamburg, DE)

Event: EHRA 2018

Congress Presentation

Add to my library

About the speaker

Professor Paulus Kirchhof

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

61 presentations

11 followers

14 more presentations in this session

Thoracoscopic versus catheter ablation for atrial fibrillation: Long-term follow-up of the FAST randomised trial

Speaker: Professor D. Kotecha (Birmingham, GB)

Discussant review - Thoracoscopic versus catheter ablation for atrial fibrillation: Long-term follow-up of the FAST randomised trial

Speaker: Professor S. Benussi (Brescia, IT)

Panel discussion

Surgical versus catheter ablation for paroxysmal and early persistent atrial fibrillation

Speaker: Doctor A. Elvan (Braunschweig, DE)

Discussant review - Surgical versus catheter ablation for paroxysmal and early persistent atrial fibrillation

Speaker: Professor J. Kautzner (Prague, CZ)

Access the full session

Late-Breaking Trials

Speakers: Professor P. Kirchhof, Professor D. Kotecha, Professor S. Benussi, Doctor A. Elvan, Professor J. Kautzner

About the event

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources